MedImmune, which is gaining hundreds of jobs as part of a consolidation by parent company AstraZeneca PLC, has completed its acquisition of AlphaCore Pharma for an undisclosed sum.
Ann Arbor, Mich.-based AlphaCore is developing a drug for high cholesterol.
Cardiovascular and metabolic disease is one of Gaithersburg-based MedImmune’s core research areas.
Click here for the full article